after transfection, the activity is rapidly cleared. CHO Plus has developed patented cell engineering technology that increases the capacity of cells to produce therapeutic proteins, and viral ...

Transfection efficiency of our chemically defined transfection agent was similar to that of other reagents (Fig. 1). Thus, L-PEI can be used for transfection at a substantially reduced cost.

The most recent and sophisticated multi-component transfection reagent, FuGENE ® 4K, was created to transfer DNA into both difficult and routine mammalian cell lines. Users are able to obtain ...

1| Harvest exponentially growing cells 24 h before transfection by trypsinization and replate them at a density of 1 × 10 5 to 4 × 10 5 cells/cm 2 in 60-mm tissue culture dishes or in 12-well ...

( ), a leading developer of biopharmaceutical manufacturing technology, announces that U.S. Patent No. 12,270,055 was issued today by the United St ...

About CHO Plus, Inc. CHO Plus, a privately held company located in South San Francisco, was founded with the mission of increasing the productivity of cells used for manufacturing life-saving ...